Prognosis
U.S. to Fund Additional 1 Billion Covid Vaccine Doses a Year
- Effort aimed at expanding domestic production of mRNA vaccines
- Biden has pledged global donations of over a billion doses
Photographer: Akos Stiller/Bloomberg
This article is for subscribers only.
President Joe Biden’s administration is offering drug manufacturers, including Pfizer Inc. and Moderna Inc., funding to expand domestic production capacity of mRNA vaccines by one billion doses a year by the second half of 2022.
The plan, announced by the White House on Wednesday, is aimed at increasing availability of Covid-19 vaccines and also building capacity to address any future pandemic.